These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15784746)

  • 1. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules.
    Baron RA; Peterson YK; Otto JC; Rudolph J; Casey PJ
    Biochemistry; 2007 Jan; 46(2):554-60. PubMed ID: 17209565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mouhcine M; Kadil Y; Segmani I; Rahmoune I; Filali H
    Curr Comput Aided Drug Des; 2024; 20(7):1055-1069. PubMed ID: 38835128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
    Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
    J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
    Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML
    Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
    Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
    Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Pan Q; Liu R; Banu H; Ma L; Li H
    Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
    Cushman I; Casey PJ
    J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
    Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    Go ML; Leow JL; Gorla SK; Schüller AP; Wang M; Casey PJ
    J Med Chem; 2010 Oct; 53(19):6838-50. PubMed ID: 20809634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
    Judd WR; Slattum PM; Hoang KC; Bhoite L; Valppu L; Alberts G; Brown B; Roth B; Ostanin K; Huang L; Wettstein D; Richards B; Willardsen JA
    J Med Chem; 2011 Jul; 54(14):5031-47. PubMed ID: 21661760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
    Zhu Y; Hu Q; Li H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
    Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
    J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells.
    Bergo MO; Leung GK; Ambroziak P; Otto JC; Casey PJ; Young SG
    J Biol Chem; 2000 Jun; 275(23):17605-10. PubMed ID: 10747846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt).
    Baron RA; Casey PJ
    BMC Biochem; 2004 Dec; 5():19. PubMed ID: 15625008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.
    Buchanan MS; Carroll AR; Fechner GA; Boyle A; Simpson MM; Addepalli R; Avery VM; Hooper JN; Su N; Chen H; Quinn RJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6860-3. PubMed ID: 17964784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.
    Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ
    Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-prenylation-processing enzymes as new targets in oncogenesis.
    Winter-Vann AM; Casey PJ
    Nat Rev Cancer; 2005 May; 5(5):405-12. PubMed ID: 15864282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.